A Nishimoto
Overview
Explore the profile of A Nishimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshino K, Terai Y, Fujimoto S, Kamata I, Kinugasa K, Nishimoto A
Interv Neuroradiol
. 2010 Jul;
6 Suppl 1:237-42.
PMID: 20667256
To date in our hospital, surgical reconstructions and percutaneous transluminal angioplasty (PTA) were carried out in 168 patients with vertebral artery (VA) stenosis at the origin. In this article, we...
2.
Nishimoto A, Narita K, Ohmoto S, Takahashi Y, Yoshizumi S, Yoshida T, et al.
Chem Pharm Bull (Tokyo)
. 2001 Sep;
49(9):1120-7.
PMID: 11558597
A series of erythromycin A 9-O-substituted oxime ether derivatives have been synthesized and evaluated for antibacterial activity against Mycobacterium avium complex (MAC) and Staphylococcus aureus. These compounds possessed stronger in...
3.
Veldtman G, Nishimoto A, Siu S, Freeman M, Fredriksen P, Gatzoulis M, et al.
Heart
. 2001 Aug;
86(3):330-5.
PMID: 11514490
Setting: Tertiary adult congenital cardiac referral centre. Design: Retrospective cross sectional analysis. Objectives: To report our 20 year experience with adult Fontan operations, and to compare late outcome in patients...
4.
Dohmen K, Senju M, Nishimoto A, Shigematsu H, Yamasaki F, Irie K, et al.
Nihon Shokakibyo Gakkai Zasshi
. 2001 Jun;
98(5):564-8.
PMID: 11400287
No abstract available.
5.
Nishimoto A, Miura N, Horikawa I, Kugoh H, Murakami Y, Hirohashi S, et al.
Oncogene
. 2001 Apr;
20(7):828-35.
PMID: 11314017
Based on the sites of frequent allelic loss in hepatocellular carcinoma, five normal human chromosomes (2, 4, 5, 10 and 16) were transferred individually into a telomerase-positive human hepatocellular carcinoma...
6.
Nishimoto A, Matsumoto Y
Clin Nephrol
. 2001 Mar;
55(2):121-6.
PMID: 11269675
Aims: Patients with end-stage renal disease often present a state of immunodeficiency. To elucidate the involvement of natural killer T (NKT) cells in the development of pathologies associated with uremia,...
7.
HIKI Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, et al.
Kidney Int
. 2001 Mar;
59(3):1077-85.
PMID: 11231363
Background: The IgA1 molecule, which is predominantly deposited in glomeruli in IgA nephropathy (IgAN), is a unique serum glycoprotein because it has O-glycan side chains in its hinge region. Our...
8.
Nishimoto A, Tomiyoshi Y, Sakemi T, Kanegae F, Nakamura M, Ikeda Y, et al.
Am J Nephrol
. 2000 Nov;
20(5):425-8.
PMID: 11093004
We herein report a very rare case of a patient suffering from simultaneous occurrence of three immune disorders, i.e. Hashimoto's thyroiditis, sarcoidosis and minimal change glomerular disease. A 66-year-old man...
9.
Odani H, HIKI Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, et al.
Biochem Biophys Res Commun
. 2000 Apr;
271(1):268-74.
PMID: 10777713
Human serum immunoglobulin IgA1 is produced in bone marrow and interacts with specific cellular receptors that mediate biological events. In this study, we have analyzed the detailed glycoform structure of...
10.
Yoshioka H, Ida S, Yokota M, Nishimoto A, Shibata S, Sugawara A, et al.
J Pharm Pharmacol
. 2000 Apr;
52(3):297-301.
PMID: 10757417
Combined treatment with lithium and valproate has been used for bipolar disorder. However, the studied interaction between these two drugs has not been fully investigated. We therefore examined the effects...